SC
Scopus BioPharma Inc.
SCPS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $25.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 164.40%
ROA 2,959.69%
Asset turnover 0.00x
Debt
70 /100
Low Current ratio 0.05x
Net debt/EBITDA 0.01x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -2.01x
EPS volatility 228.58%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SCPS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alan D. Horsager
Employees
13
Headquarters
New York City
Nadcházející události
02 PRO
Earnings
Upcoming earnings report